Cerebral venous sinus thrombosis as a recurrent thrombotic event in a patient with heterozygous prothrombin G20210A genotype after discontinuation of oral anticoagulation therapy: How long should we treat these patients with warfarin?

Journal of Thrombosis and Thrombolysis

Volumn 24, Issue 1, 2007, Pages 77-80

  Jukic, Ivana ^a   Titlic, Marina ^a   Tonkic, Ante ^a   Rosenzweig, Daniel ^b  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

^b Private Dental Clinic   (Croatia)

Author keywords

Cerebral venous sinus thrombosis; Heterozygous; Prothrombin gene G20210A mutation; Warfarin anticoagulation therapy

Indexed keywords

ADENINE; ANTICOAGULANT AGENT; GUANINE; HEPARIN; PROTHROMBIN; TICLOPIDINE; WARFARIN;

ADULT; ARTICLE; BRAIN BLOOD FLOW; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FAMILY HISTORY; GENE MUTATION; GENETIC CODE; GENETIC SCREENING; HETEROZYGOTE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LONG TERM CARE; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; RECURRENT DISEASE; SINUS VENOSUS; THROMBOPHILIA; TREATMENT DURATION; VEIN THROMBOSIS;

ADULT; ANTICOAGULANTS; DRUG ADMINISTRATION SCHEDULE; FACTOR V; GENOTYPE; HETEROZYGOTE; HUMANS; INTRACRANIAL THROMBOSIS; MALE; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN C; PROTEIN S; PROTHROMBIN; RECURRENCE; WARFARIN;

EID: 34249746697     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-006-0005-5     Document Type: Article

References (21)

1. Allroggen H, Abbott RJ (2006) Cerebral sinus venous thrombosis. Postgrad Med J 76:12-15
2. Masuhr F, Mehraein S, Einhaupl K (2004) Cerebral venous and sinus thrombosis. J Neurol 251(1):11-23
3. Rosendaal FR (1999) Venous thrombosis, a multicausal disease. Lancet 353:1167-1173
4. Khan S, Dickerman JD (2006) Hereditary thrombophilia. Thromb J 4:15
5. Koeleman BP, Reitsma PH, Bertina RM (1997) Familial thrombophilia: A complex genetic disorder. Semin Hematol 34:256-264
6. Emmerich J, Rosendaal FR, Cattaneo M et al (2001) Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism. Thromb Haemost 86:809-816
7. Ridker PM, Hennekens CH, Miletich JP (1999) G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation 99(8):999-1004
8. Leroyer C, Mercier B, Oger E et al (1998) Prevalence of 20210 A allele of the prothrombin gene in venous thromboembolism patients. Thromb Haemost 80:49-51
9. Zivelin A, Rosenberg N, Faier S et al (1998) A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene. Blood 92:1119-1124
10. Coen D, Zadro R, Honovic L, Banfic L, Stavljenic Rukavina A (2001) Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism. Croat Med J 42(4):488-492
11. Klein L, Bhardwaj V, Gebara B (2004) Cerebral venous sinus thrombosis in a neonate with homozygous prothrombin G20210A genotype. J Perinatol 24(12):797-799
12. Kurkowska-Jastrzebska I, Wicha W, Dowzenko A et al (2003) Concomitant heterozygous factor V Leiden mutation and homozygous prothrombin gene variant (G20210A) in patient with cerebral venous thrombosis. Med Sci Monit 9(5):41-45
13. Kellett MW, Martin PJ, Enevoldson TP, Brammer C, Toh CM (1998) Cerebral venous sinus thrombosis associated with 20210A mutation of the prothrombin gene. J Neurol Neurosurg Psychiatry 65(4):611-612
14. Reuner KH, Ruf A, Grau A et al (1998) Prothrombin gene G20210 → A transition is a risk factor for cerebral venous thrombosis. Stroke 29(9):1765-1769
15. Mazzoleni S, Putti MC, Simioni P et al (2005) Early cerebral sinovenous thrombosis in a child with acute lymphoblastic leukemia carrying the prothrombin G20210A variant: A case report and review of the literature. Blood Coagul Fibrinolysis 16(1):43-49
16. Verdelho A, Ferro JM, Palmeiro A, Antunes C (2001) Cerebral venous thrombosis and familial prothrombin gene G20210a mutation. Rev Neurol 33(4):335-338
17. Miles JS, Miletich JP, Goldhaber SZ, Hennekens CH, Ridker PM (2001) G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism. J Am Coll Cardiol 37(1):215-218
18. Simioni P, Prandoni P, Lensing AW et al (2000) Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis. Blood 96(10):3329-3333
19. De Stefano V, Martinelli I, Mannucci PM et al (2001) The risk of recurrent venous thromboembolism among heterozygous carriers of the G20210A prothrombin gene mutation. Br J Haematol 13(3):630-635
20. Gonzalez-Porras JR, Garcia-Sanz R, Alberca I, Lopez ML, Balanzategui A, Gutierrez O et al (2006) Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation. Blood Coagul Fibrinolysis 17(1):23-28
21. Einhaupl K, Bousser MG, de Bruijn SF, Ferro JM, Martinelli I, Masuhr F et al (2006) EFNS guideline on the treatment of cerebral venous and sinus thrombosis. Eur J Neurol 13(6):553-559